NAIROBI, Kenya – The fast-growing coronavirus crisis in India is not only forcing hospitals to ration oxygen and send families to find open beds for infected loved ones. It is also wreaking havoc on the global vaccination effort.
Nowhere is that more evident than in Africa.
Most nations relied on vaccines produced by the factory of the Serum Institute in India. But the decision by the Indian government to restrict the export of supplements to combat its own outbreak means that Africa’s already slow vaccination campaign may soon come to a close.
Before India suspended exports, more than 70 countries received vaccines manufactured by it, totaling more than 60 million doses. Many went to low and middle income countries through the Coxax program, a global initiative aimed at ensuring equitable access to the vaccine.
So far, Kovacs Have given According to Andrea Taylor, an assistant director at Duke Global Health Innovation Center, there are 43.4 million doses in 43 countries, but this represents only 2 percent of the two billion.
“Export controls from India are the primary constraint on Kovacs current supply,” she wrote in an email.
Even before India halted shipments, Africa was experiencing the slowest vaccine rollout of any continent. By 21 April, African countries, with a total population of 1.3 billion, had achieved more than 36 million vaccine doses, but were administered for only 15 million, According to Africa Centers for Disease Control and Prevention.
- On April 23, advisors from the Disease Control and Prevention Panel voted to take a stand on the Johnson & Johnson Kovid vaccine and recommend adding a label about a highly unusually dangerous potential blood clotting disorder.
- Federal health officials are expected to formally recommend that states should stop.
- The administration of the vaccine ground recently came to the vaccine after reports of the emergence of a rare blood clotting disorder in six women.
- The overall risk of developing the disorder is extremely low. Women between 30 and 39 appear to be at highest risk, with 11.8 cases given per million doses. There have been seven cases per million doses among women between 18 and 49.
- About eight million doses of the vaccine have now been administered. In men and women who are 50 or more, there have been fewer than one case per million doses.
- Johnson & Johnson had also decided to delay the rollout of its vaccine in Europe amid similar concerns, but the EU drug regulator later said the warning label should be added. South Africa was devastated by a more contagious virus variant that suspended the use of the vaccine, but later moved on with it.
Just six million doses have been administered in all of Sub-Saharan Africa – lower than in many individual US states. The prospect of low supplies is an increasingly difficult logistical challenge for many African countries, which has become complex.
Many African governments expected their doses to be higher for the population than before, in the hope that higher doses would arrive soon. Now they are struggling with what to do if there is not enough vaccine supply to deliver a two-dose dose that provides maximum prevention.
Countries such as Rwanda and Ghana, who were earlier to receive supplements from Kovacs, are about to exhaust their initial supplies. In Botswana, vaccination Temporarily stopped In some areas the allocated dose was exhausted after this month. And Kenya, which has almost run out of its initial one million dosages, said this week that it would be Johnson & Johnson and Pfizer want to acquire vaccines To continue their vaccination campaign. On Saturday, due to the delay, the country lengthened the time between administration of the first and second doses to eight to 12 weeks.
Overall, 10 African countries have the most immunizations. More than two-thirds of the supply has gone through, Regional Director of the World Health Organization for Africa, Dr. Matsidiso Moiti said.
The Immunization Task Force of the African Union has received 400 million Johnson & Johnson funds to purchase vaccines for member states – but they will not start dropping doses.
“More than a billion Africans were marginalized by this historic march to end the epidemic,” Dr. Moiti said.
A spokesman for Gavi, who helps lead the Kovacs program, said in an email that it was in close contact with the Indian government about resuming vaccination shipments, but “references to next delivery time In, we are not able to confirm this state. “
Even when the United States sits on tens of millions of doses of the AstraZeneca vaccine – the cheapest vaccine in widespread use – African nations are changing Russia And Dosage for china Carried out in those countries, despite concerns about the lack of clinical data on their efficacy and safety.
Amid delays, some African countries are experiencing new and possibly deadly waves of epidemics. The Africa Centers for Disease Control and Prevention reported 2,155 deaths from the virus in the past week, up from 1,866 a week earlier.
In Kenya’s capital Nairobi and for one of the continent’s better health care systems, officials warn of a lack of intensive care beds oxygen supply. Last month, the Kenyan government ordered a new lockdown that has sparked anger over the economic impact of the sanctions.
Back to top button